Theory Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,721
Closed -$210K 71
2023
Q2
$210K Sell
5,721
-270
-5% -$10.5K 0.12% 60
2023
Q1
$244K Hold
5,991
0.15% 57
2022
Q4
$307K Buy
+5,991
New +$287K 0.2% 52
2022
Q2
$324K Buy
6,273
+355
+6% +$18.1K 0.23% 52
2022
Q1
$306K Hold
5,918
0.2% 48
2021
Q4
$349K Buy
+5,918
New +$293K 0.23% 40

Other funds holding PFE

Theory Financial's PFE Position: Q3 2023 in Review

Theory Financial sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,721 shares — an estimated $210K sold.

Theory Financial first reported a position in PFE in Q4 2021 and held it in 6 quarters. The position peaked at $349K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Theory Financial reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Theory Financial sold 5,721 Pfizer shares in Q3 2023, an estimated $210K.
  • Theory Financial first reported a position in Pfizer in Q4 2021 and held it in 6 quarters.
  • Theory Financial's Pfizer position peaked at $349K in Q4 2021.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Theory Financial's 13F filing for Q3 2023, filed 15 Nov 2023.